Biomerica Inc.

NASDAQ: BMRA · Real-Time Price · USD
2.87
-0.64 (-18.23%)
At close: Aug 15, 2025, 9:53 AM

Biomerica Income Statement

Financials in USD. Fiscal year is June - May.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020
Revenue
1.12M 1.64M 1.81M 1.12M 1.02M 1.57M 1.71M 1.11M 1.11M 1.48M 1.64M 5.3M 7.66M 4.65M 1.26M 1.05M 3.63M 1.37M 1.14M
Cost of Revenue
1.1M 1.2M 1.52M 1.1M 1.17M 1.24M 1.3M 1.08M 991.17K 1.13M 1.69M 4.68M 5.99M 3.88M 1.35M 1.06M 3.67M 1.01M 960.93K
Gross Profit
19K 437K 289K 20K -149K 325K 412K 28.81K 120.27K 351.88K -54.95K 621.4K 1.67M 771.76K -88.97K -8.89K -38.51K 361.5K 182.88K
Operating Income
-1.21M -993K -1.37M -1.53M -2M -1.61M -1.23M -1.84M -1.65M -1.67M -2.07M -1.76M -107.5K -1.13M -1.54M -1.51M -1.88M -1.48M -1.66M
Interest Income
43K 40K 56K 114K 86K 109K 123K 55.63K 36.09K 41K n/a 6.9K 6.02K 6.92K 6.8K 12.85K 37.94K 7.98K 8.09K
Pretax Income
-1.17M -953K -1.31M -1.41M -1.91M -1.5M -1.11M -1.78M -1.62M -1.62M -2.07M -1.75M -101.48K -1.12M -1.53M -1.49M -1.84M -1.47M -1.65M
Net Income
-1.16M -950K -1.32M -1.42M -1.92M -1.51M -1.13M -1.79M -1.65M -1.63M -2.07M -1.76M -104.17K -1.13M -1.54M -1.5M -1.84M -1.49M -1.65M
Selling & General & Admin
1.01M 1.17M 1.36M 1.28M 1.51M 1.52M 1.17M 1.5M 1.38M 1.56M 1.65M 2.08M 1.32M 1.28M 1.01M 911.15K 1.28M 1.25M 1.16M
Research & Development
217K 257K 297K 265K 343K 412K 472K 368.86K 392.03K 461.94K 361.17K 297.04K 457K 618.52K 439.86K 586.19K 563.22K 586.4K 674.69K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.23M 1.43M 1.66M 1.55M 1.85M 1.93M 1.64M 1.86M 1.77M 2.02M 2.01M 2.38M 1.78M 1.9M 1.45M 1.5M 1.84M 1.84M 1.84M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 111.00 256.00 n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.33M 2.63M 3.17M 2.64M 3.02M 3.17M 2.94M 2.94M 2.76M 3.15M 3.71M 7.06M 7.77M 5.78M 2.8M 2.56M 5.51M 2.85M 2.8M
Income Tax Expense
-4K -3K 4K 7K 4K 8K 23K 13.01K 34.77K 1.25K 1.96K 9.59K 2.69K 2.43K 9.02K 1.66K -3.12K 13.39K 1.13K
Shares Outstanding (Basic)
17.12M 17.12M 16.82M 16.82M 16.82M 16.82M 16.82M 16.82M 13.48M 13.46M 12.95M 12.65M 12.82M 12.5M 12.43M 12.31M 11.8M 11.45M 11.75M
Shares Outstanding (Diluted)
17.12M 17.12M 16.82M 16.82M 16.82M 16.82M 16.82M 16.82M 13.48M 13.46M 13.1M 12.67M 12.82M 12.59M 12.43M 12.43M 11.91M 11.76M 11.75M
EPS (Basic)
-0.07 -0.06 -0.08 -0.08 -0.11 -0.09 -0.07 -0.11 -0.12 -0.12 -0.16 -0.14 -0.01 -0.09 -0.12 -0.12 -0.16 -0.13 -0.14
EPS (Diluted)
-0.07 -0.06 -0.08 -0.08 -0.11 -0.09 -0.07 -0.11 -0.12 -0.12 -0.16 -0.14 -0.01 -0.09 -0.12 -0.12 -0.15 -0.13 -0.14
EBITDA
-1.11M -993K -1.27M -1.32M -1.91M -1.52M -1.14M -1.7M -1.57M -1.62M -1.97M -1.45M -4.22K -1.03M -1.44M -1.39M -2.14M -1.68M -1.87M
EBIT
-1.21M -993K -1.37M -1.53M -2M -1.61M -1.23M -1.84M -1.65M -1.67M -2.07M -1.73M -107.5K -1.13M -1.53M -1.49M -1.84M -1.47M -1.65M
Depreciation & Amortization
99K n/a 97K 97K 94K 91K 92K 83.08K 85.76K 86.13K 96.03K 302.85K 97.26K 97.09K 97.62K 107.39K 89.01K 89.63K 89.83K